Cargando…
Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions
Identification of effective combination therapies is critical to address the emergence of drug-resistant cancers, but direct screening of all possible drug combinations is infeasible. Here we introduce a CRISPR-based double knockout (CDKO) system that improves the efficiency of combinatorial genetic...
Autores principales: | Han, Kyuho, Jeng, Edwin E., Hess, Gaelen T., Morgens, David W., Li, Amy, Bassik, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557292/ https://www.ncbi.nlm.nih.gov/pubmed/28319085 http://dx.doi.org/10.1038/nbt.3834 |
Ejemplares similares
-
A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies
por: Breslow, David K., et al.
Publicado: (2018) -
Systematic comparison of CRISPR-Cas9 and RNAi screens for essential genes
por: Morgens, David W, et al.
Publicado: (2016) -
Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens
por: Morgens, David W., et al.
Publicado: (2017) -
Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements
por: Tycko, Josh, et al.
Publicado: (2019) -
Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
por: Deans, Richard M., et al.
Publicado: (2016)